Centuple Global Ltd Fair Value
CENTUPLE · Healthcare · Current price ₹35.72
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹38 | 5% ROE fading to 13% over ~3 yrs, on ₹42 book |
| Relative P/E | ₹3 | EPS × 43.9 peer-median P/E |
| Graham floor | ₹8 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Centuple Global Ltd undervalued?
DocStoX estimates the fair value of Centuple Global Ltd at ₹23 per share, versus the current market price of ₹36. That puts the stock about -34.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹38), Relative P/E (₹3), Graham floor (₹8). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹3 (bear) to ₹23 (base) to ₹38 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Centuple Global Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.